PRINCETON, N.J., Jan. 28 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com/), a subscription service focused on semiconductor and technology stocks, announced it has published earnings previews for PMC-Sierra (NASDAQ:PMCS), Microchip Technology (NASDAQ:MCHP), Conexant Systems (NASDAQ:CNXT), Intersil (NASDAQ:ISIL), Cavium Networks (NASDAQ: CAVM), Celestica (NYSE:CLS), Cirrus Logic (NASDAQ:CRUS) and Teradyne (NYSE: TER). In 2008, Next Inning Editor Paul McWilliams guided his readers through record stock market volatility, offering stock-specific commentary throughout the challenging period. By taking a free test drive of Next Inning, you'll receive in depth earnings previews and analysis for dozens of technology companies as well as the exclusive "2009 Guide to Undervalued Tech Stocks." These reports contain McWilliams' outlooks for 2009 and his latest technology stock ratings. To accept this offer, visit the following link: https://www.nextinning.com/subscribe/index.php?refer=prn768 In his earnings previews, McWilliams looks at these topics: -- In his earnings previews, McWilliams provides commentary, data and a simple rating for each stock. The rating indicates whether the stock is a strategic investment, speculative investment, or not worth investing in at all. How does he rate the stocks you are following? -- What is the biggest wildcard facing PMC-Sierra during the first half of the year? Could PMC-Sierra double this year? -- What caused McWilliams to recently change his long-held view of Microchip? Is he bullish or bearish on the stock's prospects in 2009? -- Does McWilliams have a favorable view of Conexant? -- We've learned in the last few months that McWilliams was right to be concerned about Intersil's heavy exposure to PC markets, a concern that led him to sell his full position in 2007. Now that the stock has fallen, how does McWilliams view the stock's balance of risk and reward? -- What does McWilliams expect to hear from Cavium on its Q4 conference call? Does McWilliams recommend investors consider Cavium a strategic investment in 2009? -- Could Celestica triple during the next up-cycle? -- Does Cirrus Logic's balance sheet protect it from further downside pressure? Is McWilliams expecting the stock to rebound in 2009? -- With 40% of its price represented by its net cash position, does Teradyne merit attention from investors? Founded in September 2002, Next Inning's model portfolio has returned 130% since its inception versus 16% for the Nasdaq. About Next Inning: Next Inning is a subscription financial newsletter focused on technology stocks. Editor Paul McWilliams is a 20+-year semiconductor industry veteran. NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. CONTACT: Marcia Wilmot Next Inning Technology Research, +1-888-278-5515 DATASOURCE: Indie Research Advisors, LLC CONTACT: Marcia Wilmot, Next Inning Technology Research, +1-888-278-5515 Web Site: http://www.nextinning.com/

Copyright